BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rainero I, Rubino E, Gallone S, Fenoglio P, Picci LR, Giobbe L, Ostacoli L, Pinessi L. Evidence for an association between migraine and the hypocretin receptor 1 gene. J Headache Pain 2011;12:193-9. [PMID: 21344296 DOI: 10.1007/s10194-011-0314-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Bag A, Bhoi SK, Jha M, Palo GD. Sleep quality evaluation, correlation with headache frequency, and propensity to conversion from episodic to chronic daily headache in migraine patients: A cross-sectional study. JNRP 2022;0:1-8. [DOI: 10.25259/jnrp-2022-2-28] [Reference Citation Analysis]
2 Hamit G, Ayca O, Omer B, Nevra O, Aynur O. Association of circadian locomotor output cycles kaput rs1801260 and hypocretin receptor 1 rs2271933 polymorphisms in patients with chronic migraine and sleep disorder. Neurol Sci Neurophysiol 2022;39:98. [DOI: 10.4103/nsn.nsn_195_21] [Reference Citation Analysis]
3 İnce H, Aydin ÖF, Alaçam H, Çetinoğlu EÇ. COMPARATIVE ANALYSIS OF PLASMA OREXIN A AND OREXIN B LEVELS IN PEDIATRIC MIGRAINE PATIENTS: A PROSPECTIVE CONTROLLED CLINICAL STUDY. Middle Black Sea Journal of Health Science 2021. [DOI: 10.19127/mbsjohs.908941] [Reference Citation Analysis]
4 Askari-Zahabi K, Abbasnejad M, Kooshki R, Esmaeili-Mahani S. Orexin one receptors within the basolateral amygdala are involved in the modulation of cognitive deficits associated with a migraine-like state in rats. Neurol Res 2021;:1-11. [PMID: 34233602 DOI: 10.1080/01616412.2021.1949687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Diamond JA, Natbony LR. Headache and Sleep. Integrative Headache Medicine 2021. [DOI: 10.1007/978-3-030-71513-7_6] [Reference Citation Analysis]
6 Kooshki R, Abbasnejad M, Esmaeili-mahani S, Raoof M, Sheibani V. Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus caudalis of rats. Neuropharmacology 2020;178:107981. [DOI: 10.1016/j.neuropharm.2020.107981] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
7 Pulver A, Kiive E, Kanarik M, Harro J. Association of orexin/hypocretin receptor gene (HCRTR1) with reward sensitivity, and interaction with gender. Brain Res 2020;1746:147013. [PMID: 32652147 DOI: 10.1016/j.brainres.2020.147013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Harro J, Laas K, Eensoo D, Kurrikoff T, Sakala K, Vaht M, Parik J, Mäestu J, Veidebaum T. Orexin/hypocretin receptor gene (HCRTR1) variation is associated with aggressive behaviour. Neuropharmacology 2019;156:107527. [DOI: 10.1016/j.neuropharm.2019.02.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
9 Roccella M, Marotta R, Operto FF, Smirni D, Precenzano F, Bitetti I, Messina G, Sessa F, Di Mizio G, Loreto C, Salerno M, Russo V, Murabito P, Gallai B, Esposito M, Iacono D, Carotenuto M. NREM Sleep Instability in Pediatric Migraine Without Aura. Front Neurol 2019;10:932. [PMID: 31551903 DOI: 10.3389/fneur.2019.00932] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
10 Cengiz M, Karaj V, Kocabasoğlu N, Gozubatik-celik G, Dirican A, Bayoglu B. Orexin/hypocretin receptor, Orx 1 , gene variants are associated with major depressive disorder. International Journal of Psychiatry in Clinical Practice 2019;23:114-21. [DOI: 10.1080/13651501.2018.1551549] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
11 Amin FM, Aristeidou S, Baraldi C, Czapinska-Ciepiela EK, Ariadni DD, Di Lenola D, Fenech C, Kampouris K, Karagiorgis G, Braschinsky M, Linde M; European Headache Federation School of Advanced Studies (EHF-SAS). The association between migraine and physical exercise. J Headache Pain 2018;19:83. [PMID: 30203180 DOI: 10.1186/s10194-018-0902-y] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 12.2] [Reference Citation Analysis]
12 Kowalska M, Kapelusiak-Pielok M, Grzelak T, Wypasek E, Kozubski W, Dorszewska J. The New *G29A and G1222A of HCRTR1, 5-HTTLPR of SLC6A4 Polymorphisms and Hypocretin-1, Serotonin Concentrations in Migraine Patients. Front Mol Neurosci 2018;11:191. [PMID: 29922128 DOI: 10.3389/fnmol.2018.00191] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
13 Messina A, Bitetti I, Precenzano F, Iacono D, Messina G, Roccella M, Parisi L, Salerno M, Valenzano A, Maltese A, Salerno M, Sessa F, Albano GD, Marotta R, Villano I, Marsala G, Zammit C, Lavano F, Monda M, Cibelli G, Lavano SM, Gallai B, Toraldo R, Monda V, Carotenuto M. Non-Rapid Eye Movement Sleep Parasomnias and Migraine: A Role of Orexinergic Projections. Front Neurol 2018;9:95. [PMID: 29541053 DOI: 10.3389/fneur.2018.00095] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
14 Kummer KK, Kalpachidou T, Kress M, Langeslag M. Signatures of Altered Gene Expression in Dorsal Root Ganglia of a Fabry Disease Mouse Model. Front Mol Neurosci 2017;10:449. [PMID: 29422837 DOI: 10.3389/fnmol.2017.00449] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
15 Kowalska M, Prendecki M, Kozubski W, Lianeri M, Dorszewska J. Molecular factors in migraine. Oncotarget 2016;7:50708-18. [PMID: 27191890 DOI: 10.18632/oncotarget.9367] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
16 Ferroni P, Barbanti P, Della-Morte D, Palmirotta R, Jirillo E, Guadagni F. Redox Mechanisms in Migraine: Novel Therapeutics and Dietary Interventions. Antioxid Redox Signal 2018;28:1144-83. [PMID: 28990418 DOI: 10.1089/ars.2017.7260] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
17 Thompson MD, Sakurai T, Rainero I, Maj MC, Kukkonen JP. Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics. Pharmaceuticals (Basel) 2017;10:E79. [PMID: 28991183 DOI: 10.3390/ph10040079] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
18 Atcherley CW, Nation K, Felice MD, Xie JY, Ossipov MH, Dodick DW, Porreca F. Central Circuits Promoting Chronification of Migraine. Neurobiological Basis of Migraine 2017. [DOI: 10.1002/9781118967225.ch8] [Reference Citation Analysis]
19 Gauci S, Hosking W, Bruck D, Schumacher U. Narcolepsy, cataplexy, hypocretin and co-existing other health complaints: A review. Cogent Medicine 2017;4:1312791. [DOI: 10.1080/2331205x.2017.1312791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Zorina-lichtenwalter K, Meloto C, Khoury S, Diatchenko L. Genetic predictors of human chronic pain conditions. Neuroscience 2016;338:36-62. [DOI: 10.1016/j.neuroscience.2016.04.041] [Cited by in Crossref: 111] [Cited by in F6Publishing: 117] [Article Influence: 15.9] [Reference Citation Analysis]
21 Kondratieva N, Azimova J, Skorobogatykh K, Sergeev A, Naumova E, Kokaeva Z, Anuchina A, Rudko O, Tabeeva G, Klimov E. Biomarkers of migraine: Part 1 – Genetic markers. Journal of the Neurological Sciences 2016;369:63-76. [DOI: 10.1016/j.jns.2016.08.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
22 Farooqui T. Trace Amines and Their Potential Role in Primary Headaches. Trace Amines and Neurological Disorders 2016. [DOI: 10.1016/b978-0-12-803603-7.00024-0] [Reference Citation Analysis]
23 Suzuki K, Miyamoto M, Miyamoto T, Inoue Y, Matsui K, Nishida S, Hayashida K, Usui A, Ueki Y, Nakamura M, Murata M, Numao A, Watanabe Y, Suzuki S, Hirata K. The Prevalence and Characteristics of Primary Headache and Dream-Enacting Behaviour in Japanese Patients with Narcolepsy or Idiopathic Hypersomnia: A Multi-Centre Cross-Sectional Study. PLoS One 2015;10:e0139229. [PMID: 26418536 DOI: 10.1371/journal.pone.0139229] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
24 Holland PR. Headache and sleep: shared pathophysiological mechanisms. Cephalalgia 2014;34:725-44. [PMID: 25053747 DOI: 10.1177/0333102414541687] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
25 Thompson MD, Xhaard H, Sakurai T, Rainero I, Kukkonen JP. OX1 and OX2 orexin/hypocretin receptor pharmacogenetics. Front Neurosci 2014;8:57. [PMID: 24834023 DOI: 10.3389/fnins.2014.00057] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
26 Abdallah K, Artola A, Monconduit L, Dallel R, Luccarini P. Bilateral descending hypothalamic projections to the spinal trigeminal nucleus caudalis in rats. PLoS One 2013;8:e73022. [PMID: 23951340 DOI: 10.1371/journal.pone.0073022] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
27 Vollono C, Gnoni V, Testani E, Dittoni S, Losurdo A, Colicchio S, Di Blasi C, Mazza S, Farina B, Della Marca G. Heart rate variability in sleep-related migraine without aura. J Clin Sleep Med 2013;9:707-14. [PMID: 23853566 DOI: 10.5664/jcsm.2846] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
28 Durham P, Papapetropoulos S. Biomarkers associated with migraine and their potential role in migraine management. Headache 2013;53:1262-77. [PMID: 23848170 DOI: 10.1111/head.12174] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 5.6] [Reference Citation Analysis]
29 Rainero I, Rubino E, Paemeleire K, Gai A, Vacca A, De Martino P, Gentile S, Sarchielli P, Pinessi L. Genes and primary headaches: discovering new potential therapeutic targets. J Headache Pain 2013;14:61. [PMID: 23848401 DOI: 10.1186/1129-2377-14-61] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
30 Gotter AL, Webber AL, Coleman PJ, Renger JJ, Winrow CJ. International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology. Pharmacol Rev 2012;64:389-420. [DOI: 10.1124/pr.111.005546] [Cited by in Crossref: 124] [Cited by in F6Publishing: 133] [Article Influence: 11.3] [Reference Citation Analysis]
31 Gotter AL, Roecker AJ, Hargreaves R, Coleman PJ, Winrow CJ, Renger JJ. Orexin receptors as therapeutic drug targets. Prog Brain Res 2012;198:163-88. [PMID: 22813974 DOI: 10.1016/B978-0-444-59489-1.00010-0] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 6.7] [Reference Citation Analysis]
32 Negro A, Martelletti P. Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain 2011;12:593-601. [PMID: 21938457 DOI: 10.1007/s10194-011-0388-3] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 6.2] [Reference Citation Analysis]